[Tumor markers in C-cell cancer]

Area of Science:

• Endocrinology
• Oncology
• Biomarker Research

Background:

• C-cell carcinoma, also known as medullary thyroid carcinoma, is characterized by elevated serum calcitonin levels.
• Other tumor markers such as carcinoembryonic antigen (CEA), adrenocorticotrophic hormone (ACTH), and tissue polypeptide antigen (TPA) can also be increased.

Purpose of the Study:

• To evaluate the clinical relevance of various tumor markers compared to calcitonin in patients with C-cell carcinoma.
• To assess the diagnostic and prognostic value of calcitonin, CEA, ACTH, and TPA in medullary thyroid carcinoma.

Main Methods:

• Analysis of serum calcitonin, CEA, ACTH, and TPA levels in 46 patients diagnosed with C-cell carcinoma.
• Correlation analysis between tumor marker levels and clinical tumor stage.
• Comparison of marker sensitivity and specificity for C-cell carcinoma detection and monitoring.
• Evaluation of calcitonin and CEA in selective venous catheterization for tumor localization.

Main Results:

• Pathologically increased levels were observed with decreasing frequency: calcitonin (93%), CEA (73%), TPA (17%), and ACTH (8%).
• A positive correlation was found between calcitonin and CEA levels, both of which correlated with clinical tumor stage.
• Calcitonin was found to be superior to CEA in selective venous catheterization.
• CEA assessment complements calcitonin measurements in follow-up and treatment evaluation.

Conclusions:

• Calcitonin is the most sensitive and specific tumor marker for C-cell carcinoma among those tested.
• Calcitonin and CEA are valuable for staging and monitoring treatment response in medullary thyroid carcinoma.
• While CEA is a useful supplementary marker, calcitonin remains the primary biomarker for C-cell carcinoma.